Physician profile
Urva Naik
NPI 1194089979
$626.22
in general payments reported to CMS, 2019-2025
17 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2021: $25.37 · 2022: $146 · 2023: $22.83 · 2024: $84.95 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $76.49 | 2019-2022 | |
| Channel Medsystems, INC. | $75.41 | 2025 | |
| Hologic Sales and Service, LLC | $68.86 | 2021-2025 | Novasure, Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $55.60 | 2019-2022 | |
| Organon LLC | $54.87 | 2022 | |
| Amag Pharmaceuticals, INC. | $47.35 | 2019 | |
| Astellas Pharma US INC | $43.84 | 2023-2024 | Veozah |
| Exact Sciences Corporation | $38.01 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $31.31 | 2019 | |
| Ascend Therapeutics US, LLC | $22.72 | 2022 | |
| Sage Therapeutics, LLC | $21.82 | 2025 | Zurzuvae |
| Bard Access Systems, INC. | $21.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.81 | 2022 | |
| Duchesnay USA Incorporated | $14.28 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.81 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $12.46 | 2019 | |
| Pfizer INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Urva Naik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.